Metharbital
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
5,5-Diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
Clinical data | |
AHFS/Drugs.com | monograph |
Identifiers | |
CAS Number | 50-11-3 |
ATC code | N03AA30 (WHO) |
PubChem | CID: 4099 |
IUPHAR/BPS | 7230 |
DrugBank | DB00463 |
ChemSpider | 3957 |
UNII | 02OS7K758T |
KEGG | D01382 |
ChEMBL | CHEMBL450 |
Synonyms | Endiemal, metharbitone, methobarbitone[1] |
Chemical data | |
Formula | C9H14N2O3 |
Molecular mass | 198.219 g/mol |
|
|
|
|
(verify) |
Metharbital was patented in 1905 by Emil Fischer working for Merck.[2] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy.[3][4] It has similar properties to phenobarbital.
History
- 1952 Gemonil was introduced by Abbott Laboratories.
- 1990 Abbott stopped marketing.
Synthesis
Metharbital can be synthesized from 2,2-diethylmalonic acid and O-methylisourea.[5][6][7]
References
- ↑ The Comparative Toxicogenomics Database: Metharbital
- ↑ US Patent 782742
- ↑ The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
- ↑ The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5
- ↑ A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949)
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ U.S. Patent 782,742
<templatestyles src="Asbox/styles.css"></templatestyles>